CASH Stock Analysis: Meta Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.873m USD | 12M Return: 9.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 20.2M
EPS Trend: 93.6%
Qual. Beats: 0
Rev. Trend: 95.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pathward Financial, Inc. is a U.S. bank holding company operating through Pathward, National Association, with three reporting segments: Consumer, Commercial, and Corporate Services/Other. Its offerings span demand, savings, and money market deposit accounts, along with a broad commercial finance suite that includes term lending, asset-based lending, factoring, lease financing, insurance premium finance, and government-guaranteed lending. On the consumer side, the company provides installment and revolving lending products, tax-related services such as short-term refund advance loans, and warehouse financing for mortgage originators.
The firm also runs a meaningful payments business, processing credit and debit card transactions, servicing freestanding ATMs, supporting digital payments and merchant services, and issuing its own debit and prepaid cards. Founded in 1954 and headquartered in Sioux Falls, South Dakota, the company was renamed from Meta Financial Group to Pathward Financial in July 2022. As a small-cap regional bank trading on NASDAQ under the ticker CASH, Pathwards mix of niche lending, tax-refund advances, and prepaid card issuance distinguishes it from more traditional deposit-driven regional banks.
- Tax refund advance volume drives seasonal consumer segment swings
- BaaS and prepaid card partnerships accelerate payment solutions revenue
- Net interest margin compresses as Fed rate cuts pressure asset yields
| Net Income: 188.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.75 > 1.0 |
| NWC/Revenue: -799.1% < 20% (prev -645.0%; Δ -154.1% < -1%) |
| CFO/TA 0.09 > 3% & CFO 675.3m > Net Income 188.9m |
| Net Debt (-92.9m) to EBITDA (280.9m): -0.33 < 3 |
| Current Ratio: 0.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.7m) vs 12m ago -8.65% < -2% |
| Gross Margin: 91.94% > 18% (prev 52.94%; Δ 39.00% > 0.5%) |
| Asset Turnover: 10.91% > 50% (prev 9.44%; Δ 1.47% > 0%) |
| Interest Coverage Ratio: 21.67 > 6 (EBIT TTM 225.4m / Interest Expense TTM 10.4m) |
| A: -0.87 (Total Current Assets 193.7m - Total Current Liabilities 6.35b) / Total Assets 7.11b |
| B: 0.05 (Retained Earnings 340.7m / Total Assets 7.11b) |
| C: 0.03 (EBIT TTM 225.4m / Avg Total Assets 7.06b) |
| D: 0.14 (Book Value of Equity 851.5m / Total Liabilities 6.26b) |
| Altman-Z'' = -5.17 = D |
| DSRI: 0.84 (Receivables 36.1m/37.1m, Revenue 770.5m/661.7m) |
| GMI: 0.58 (GM 52.94% / 91.94%) |
| AQI: 1.46 (AQ_t 0.94 / AQ_t-1 0.64) |
| SGI: 1.16 (Revenue 770.5m / 661.7m) |
| TATA: -0.07 (NI 188.9m - CFO 675.3m) / TA 7.11b) |
| Beneish M = -3.16 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at USD 90.44 with a total of 160,626 shares traded. Over the past week, the price has changed by +4.65%, over one month by +12.57%, over three months by -2.28% and over the past year by +9.33%.
Current recommended Stop Loss: 85.50 (which is 5.5% or 2 ATR below the current price).
Meta Financial has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold CASH.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 107.5 | 18.9% |
P/E Trailing = 10.5619
P/E Forward = 11.236
P/S = 2.4099
P/B = 2.2006
P/EG = 0.2023
Revenue TTM = 770.5m USD
EBIT TTM = 225.4m USD
EBITDA TTM = 280.9m USD
Long Term Debt = 33.5m USD (from longTermDebt, last quarter)
Short Term Debt = 26.0m USD (from shortTermDebt, last quarter)
Debt = 64.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 5.19m
Net Debt = -92.9m USD (calculated: Debt 64.7m - CCE 157.6m)
Enterprise Value = 1.78b USD (1.87b + Debt 64.7m - CCE 157.6m)
Interest Coverage Ratio = 21.67 (Ebit TTM 225.4m / Interest Expense TTM 10.4m)
EV/FCF = 3.54x (Enterprise Value 1.78b / FCF TTM 502.1m)
FCF Yield = 28.21% (FCF TTM 502.1m / Enterprise Value 1.78b)
FCF Margin = 65.17% (FCF TTM 502.1m / Revenue TTM 770.5m)
Net Margin = 24.52% (Net Income TTM 188.9m / Revenue TTM 770.5m)
Gross Margin = 91.94% ((Revenue TTM 770.5m - Cost of Revenue TTM 62.1m) / Revenue TTM)
Gross Margin QoQ = 81.79% (prev none%)
Tobins Q-Ratio = 0.25 (Enterprise Value 1.78b / Total Assets 7.11b)
Interest Expense / Debt = 16.08% (Interest Expense 10.4m / Debt 64.7m)
Taxrate = 15.73% (35.5m / 225.4m)
NOPAT = 190.0m (EBIT 225.4m * (1 - 15.73%))
Current Ratio = 0.03 (Total Current Assets 193.7m / Total Current Liabilities 6.35b)
Debt / Equity = 0.08 (Debt 64.7m / totalStockholderEquity, last quarter 851.5m)
Debt / EBITDA = -0.33 (Net Debt -92.9m / EBITDA 280.9m)
Debt / FCF = -0.19 (Net Debt -92.9m / FCF TTM 502.1m)
Total Stockholder Equity = 845.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.67% (Net Income 188.9m / Total Assets 7.11b)
RoE = 22.34% (Net Income TTM 188.9m / Total Stockholder Equity 845.8m)
RoCE = 25.64% (EBIT 225.4m / Capital Employed (Equity 845.8m + L.T.Debt 33.5m))
RoIC = 2.69% (NOPAT 190.0m / Invested Capital 7.07b)
WACC = 9.00% (E(1.87b)/V(1.94b) * Re(8.84%) + D(64.7m)/V(1.94b) * Rd(16.08%) * (1-Tc(0.16)))
Discount Rate = 8.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -7.37%
[DCF] Terminal Value 75.90% ; FCFF base≈366.0m ; Y1≈419.5m ; Y5≈617.5m
[DCF] Fair Price = 399.6 (EV 8.34b - Net Debt -92.9m = Equity 8.43b / Shares 21.1m; r=9.00% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 93.62 | EPS CAGR: 15.83% | SUE: 0.0 | # QB: 0
Revenue Correlation: 95.73 | Revenue CAGR: 9.57% | SUE: 0.23 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.95 | Chg30d=+0.00% | Revisions=+17% | Analysts=3
EPS current Year (2026-09-30): EPS=8.68 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+18.3% | GrowthRev=-1.7%
EPS next Year (2027-09-30): EPS=9.67 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+11.5% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: +22% (up=4, down=2)